“Our strategic intent for the Water Solutions business is to have a robust portfolio of technologies so that our talented global organization can leverage a broad range of solutions to solve our customers’ most pressing challenges,” said Marc Doyle, DuPont chief executive officer. “Recently, we announced the intended acquisition of BASF’s ultrafiltration membrane business. This second announcement reinforces our commitment to invest in specialty solutions aligned with high growth, attractive end markets where our continued innovation and customer relationships add value.”
DuPont made the acquisition to expand its portfolio of water purification and separation capabilities with ultrafiltration and membrane biofiltration (MBR) technologies.
“DuPont and Evoqua have enjoyed a mutually beneficial long-standing business relationship, and this transaction further complements both companies’ strengths to focus more effectively on what each does best,” said HP Nanda, global vice president and general manager and DuPont Water Solutions. “The addition of Evoqua’s ultrafiltration portfolio opens DuPont Water Solutions to additional market spaces including membrane bioreactors, submerged and pressurized ultrafiltration systems bringing more choice and opportunity for customers.”
The transaction is expected to close by the end of 2019, subject to closing conditions and regulatory approvals.